Your browser doesn't support javascript.
loading
Treatment of mild-to-moderate asthma in childhood and adolescence in 2021.
Abrams, Elissa M; Shaker, Marcus; Greenhawt, Matthew; Fernandes, Ricardo M; Sinha, Ian.
Affiliation
  • Abrams EM; Department of Pediatrics, Section of Allergy and Clinical Immunology, University of Manitoba, Winnipeg R2A 5L9, MB, Canada; Department of Pediatrics, Division of Allergy and Immunology, University of British Columbia, Vancouver, BC, Canada. Electronic address: eabram10@jhu.edu.
  • Shaker M; Dartmouth-Hitchcock Medical Center, Section of Allergy and Immunology, Lebanon, NH, USA; Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
  • Greenhawt M; Section of Allergy/Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA.
  • Fernandes RM; Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal; Department of Pediatrics, Santa Maria Hospital, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Center, Lisbon, Portugal.
  • Sinha I; Alder Hey Children's Hospital, Liverpool, UK; Division of Child Health, University of Liverpool, Liverpool, UK.
Lancet Respir Med ; 9(5): 443-445, 2021 05.
Article in En | MEDLINE | ID: mdl-33721559

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Asthma / Cost of Illness / Anti-Asthmatic Agents Aspects: Patient_preference Limits: Adolescent / Child / Child, preschool / Humans Language: En Journal: Lancet Respir Med Year: 2021 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Asthma / Cost of Illness / Anti-Asthmatic Agents Aspects: Patient_preference Limits: Adolescent / Child / Child, preschool / Humans Language: En Journal: Lancet Respir Med Year: 2021 Document type: Article Country of publication: United kingdom